Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2014-09-15, 12:31:02 | version 1.32.01
8. Muris J, Kleverlaan CJ, Feilzer AJ, et al. Sodium tetrachloropalladate (Na2[PdCl4]) as an improved test salt for palladium allergy patch testing. Contact Dermatitis 2008; 58: 42-6. 9. Toebak MJ, Gibbs S, Bruynzeel DP, et al. Dendritic cells: biology of the skin. Contact Dermatitis 2009; 60: 2-20. Cutaneous Lymphoma When Rein Willemze joined the staff of the department, he continued his research on cutaneous lymphomas, which had started in Leiden. In Amsterdam, the successful collaboration with Chris Meijer, who had moved from Leiden to become department head of pathology at the VU University in 1982, was reinforced. In October 1985 the multidisciplinary Dutch Cutaneous Lymphoma Group was constituted, and with it a national database for patients with a cutaneous lymphoma, thus making the department the national referral center for this patient group. Because of the multi- disciplinary approach allowing optimal clinicopathologic correlation and the availability of relatively large groups of patients with uncommon types of cutaneous lymphoma in the national database, it became possible to define new types of cutaneous T-cell lymphoma and cutaneous B-cell lymphoma, and to formulate a new classification system for primary cutaneous lymphomas (EORTC classification, 1997).[1-5] Apart from clinical and clinicopathologic studies and the development of new diagnostic techniques, basic research also focused on keratinocyte-T-cell interactions and the role of cytokines and chemokines in cutaneous T-cell lymphoma and skin inflammation.[6-10] In 2000 Rein Willemze left the department to become department head of dermatology in Leiden, where the cutaneous lymphoma research came to be continued. References 1. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous T cell lymphoma with a favorable prognosis. An European multicenter study on 47 cases. Cancer 1993; 71: 2097-2104. 2. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30+ lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993; 28: 973-80. 3. Vermeer MH, Geelen FAMJ, van Haselen CW, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 1996; 132: 1304-8. 4. Doorn R van, Scheffer E, Willemze R. Follicular mycosis fungoides with or without associated follicular mucinosis: a distinct disease entity. Arch Dermatol 2002; 138: 191-8. 5. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas. Consensus report of the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 1997; 90: 354-71. 6. Rijlaarsdam JU, Toonstra J, Meijer OWM, et al. Treatment of primary cutaneous B-cell lymphomas of follicular center cell origin. A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 1996; 14: 549-55. 122 BWEADVSMGFINCORR:Opmaak 1 21-07-2014 17:40 Pagina 122